Genomic Epidemiology is a cutting-edge field that integrates genomics and epidemiology to study the spread and evolution of diseases within populations. By analyzing the genetic material of pathogens, such as viruses and bacteria, researchers can gain valuable insights into the dynamics of infectious diseases. This approach allows for a more precise understanding of transmission patterns, source identification, and the development of targeted prevention and control strategies. Through next-generation sequencing technologies, genomic epidemiology provides a high-resolution view of the genetic variations within pathogens. This helps track the emergence of new strains, understand their evolution, and assess their potential impact on public health. Genomic data can uncover hidden transmission networks, elucidate the origins of outbreaks, and aid in the identification of key reservoirs or vectors. Advancements in computational biology and bioinformatics play a crucial role in interpreting vast genomic datasets. The integration of epidemiological data with genomic information enhances our ability to predict disease trajectories and tailor interventions. Genomic epidemiology has proven particularly valuable in combating infectious diseases like COVID-19, enabling rapid response efforts and the development of targeted vaccines. As the field continues to evolve, genomic epidemiology holds promise for addressing global health challenges, informing public health policies, and advancing our understanding of the intricate interplay between pathogens and human populations. This interdisciplinary approach is shaping the future of epidemiology, offering powerful tools to enhance disease surveillance, control, and prevention strategies.
Speaker lineup for this track will be announced soon.
Browse all speakers →From 2022 to 2023, the United States faced its largest outbreak of Candida auris infections in Las Vegas, Nevada. In response, our multi-disciplinary team, including engineers, geneticists, and…
The COVID-19 pandemic in the United States was exacerbated by the inability to track infections in a timely manner. Testing of humans revealed new public health challenges due to the lack of test…
Understanding disease burden and transmission dynamics in resource-limited, developing countries like Nepal is often challenging due to a lack of adequate surveillance systems. These issues are…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Genomic Epidemiology work, reviewed by the scientific committee.
Meet public health researchers, educators, and policy leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Genomic Epidemiology research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Genomic Epidemiology track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Genomic Epidemiology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Genomic Epidemiology are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IPHC 2027 is a hybrid conference — attend the Genomic Epidemiology track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
